CRISPR Therapeutics AG (CRSP)
AI Score
Our AI model analyzes fundamental, technical, and statistical indicators
to predict the probability of a bullish trend over the next three months.
We regularly update and refine our models to deliver the most reliable forecasts
for you.
Bullish Probability | Sentiment | Score |
---|---|---|
+80% | Strong Buy | 10 |
+75% | Buy | 9 |
+70% | Buy | 8 |
+60% | Buy | 7 |
+50% | Hold | 6 |
+45% | Hold | 5 |
+40% | Hold | 4 |
+35% | Sell | 3 |
+30% | Sell | 2 |
+20% | Strong Sell | 1 |
44.16
-0.04 (-0.09%)
At close: Jan 23, 2025, 3:59 PM
44.23
0.17%
After-hours Jan 23, 2025, 05:31 PM EST
Hottest Contracts (Highest Volume)
Chain | DTE | % OTM | Last | Low-High | Volume | OI | OI Change | IV | Total Prem |
---|---|---|---|---|---|---|---|---|---|
Call | 29D | 35.88% | 0.4 | 0.1-0.75 | 4,358 | 322 | +82 | 76% | 14.49K |
Call | 8D | 4.18% | 1.4 | 0.25-2.2 | 4,093 | 51 | +14 | 73% | 7.04K |
Call | 1D | 1.91% | 0.9 | 0.03-1.89 | 3,666 | 175 | +105 | 77% | 15.40K |
Highest OI Contracts
Chain | DTE | % OTM | Last | Low-High | Volume | OI | OI Change | IV | Total Prem |
---|---|---|---|---|---|---|---|---|---|
Call | 358D | 103.82% | 2.5 | 2.3-2.5 | 387 | 1,506 | -3 | 60% | 353.91K |
Call | 358D | 205.73% | 0.8 | 0.5-0.8 | 155 | 1,309 | +2 | 62% | 95.56K |
Call | 84D | 13.23% | 3.4 | 1.9-3.9 | 359 | 1,251 | +9 | 62% | 425.34K |
Trade Smarter, Not Harder
Cut through market noise with actionable insights that actually help you make confident investment decisions. No more endless research or gut-based guessing.
- Unlimited access to all data and tools
- Unlimited access to all data and tools, giving you the edge over everyone else in the market.
- Realtime Options Data
- Instant access to live options data to spot opportunities and trade with precision before the market moves.
- Top Wallstreet Analyst Ratings
- Follow ratings from the best analysts on Wall Street to stay ahead.
- Up to 30 years financial history
- We deliver premium Wall Street data with top-tier accuracy and up to 30 years of history.